Talk:Indiana Biosciences Research Institute
Latest comment: 1 year ago by Ibricommsdirector in topic Ibricommsdirector
 | This article has not yet been rated on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Ibricommsdirector edit
 | The following Wikipedia contributor may be personally or professionally connected to the subject of this article. Relevant policies and guidelines may include conflict of interest, autobiography, and neutral point of view. |
I understand I may have a conflict of interest as I am the director of communications and engagement at the Indiana Bioscience Research Institute. I simply endeavor to update the entry to align with our current strategy and updated website that clearly identifies current board members, etc. Ibricommsdirector (talk) 15:51, 2 August 2022 (UTC)
- {{request edit}} Please change opening short description to align with this organization's current strategy as reflected on its website, www.indianabiosciences.org.
- A more appropriate short description might read, "The Indiana Biosciences Research Institute (IBRI) is an American nonprofit headquartered in Indianapolis, Indiana, within the 16 Tech Innovation District. The IBRI is a leading translational research institute that advances academic and industry science through collaboration to improve patient health outcomes. Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes. Its goal is to translate this knowledge into novel therapies, while also looking to expand into other diseases that share common systems and pathways." Ibricommsdirector (talk) 16:05, 2 August 2022 (UTC)
- {{request edit}} Please add other social media channels to the external links.
- IBRI on LinkedIn - https://www.linkedin.com/company/indiana-biosciences-research-institute
- IBRI on Instagram - https://www.instagram.com/inbiosciences/
- IBRI on Facebook - https://www.facebook.com/INBiosciences/ Ibricommsdirector (talk) 16:12, 2 August 2022 (UTC)
- {{request edit}} Please remove the IBRI Scientific Advisory Board list as the organization no longer uses this board. Ibricommsdirector (talk) 16:16, 2 August 2022 (UTC)
- {{request edit}} Please update the IBRI's Board of Directors to reflect the current list that includes:
- Robert Bernhard, University of Notre Dame
- Wayne Burris, Roche Diagnostics Corporation
- Kenneth Custer, Eli Lilly and Company
- Daniel Evans, Jr., Indiana University Health
- Tatiana Foroud, Indiana University School of Medicine
- Jay Hess, Indiana University
- David Ingram, Indiana University Health
- Cris Johnston, Indiana Office of Management and Budget
- John Lechleiter, Eli Lilly and Company
- Patricia Martin, BioCrossroads, Inc.
- Theresa Mayer, Purdue University
- Hany Moselhi, Roche Diagnostics North America
- Alan Palkowitz, Indiana Biosciences Research Institute
- Dan Peterson, Cook Group, Inc.
- Aaron Schacht, BiomEdit, LLC
- Wendy Srnic, Corteva Agriscience
- Bill Stephan, Indiana University Ibricommsdirector (talk) 16:21, 2 August 2022 (UTC)